The MosaiQ solution is a next-generation IVD solution for autoimmune diseases, allergies and beyond. The multiplexed, fully automated planar microarray platform enables syndromic testing for complex ...
EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ — AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac Disease ...
All reagents and multiplex microarray magazines are equipped with RFID tags to save time while avoiding manual errors. Unique combination of tests The MosaiQ AiPlex CTDplus assay enables a syndromic ...
EYSINS, Switzerland, Feb. 3, 2025 /PRNewswire/ -- AliveDx announces the receipt of IVDR-CE mark for its MosaiQ AiPlex ® CTDplus multiplex assay. The multiplex assay enables a syndromic approach, ...
BOSTON--(BUSINESS WIRE)--Sengenics today announced the commercial launch of the i-Ome® Protein Array Kit. The i-Ome® Protein Array Kit contains slide-based, high density protein microarrays, comprised ...
State-of-the-art facility offers increased capacity and enhanced process automation to meet the growing demand for Aushon's multiplex immunoassay products and services Billerica, Mass.,Sep 9, 2009 - ...
(*𝐍𝐎𝐓𝐄: 𝐓𝐨 𝐠𝐞𝐭 𝐜𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐭𝐨 𝐲𝐨𝐮𝐫 𝐥𝐢𝐤𝐢𝐧𝐠 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐀𝐃𝐃 / 𝐑𝐄𝐌𝐎𝐕𝐄 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 ...
Analysis of gene expression is critical to understanding the molecular underpinnings of normal and disease processes. Although in recent years the field has been flooded with microarray data, a ...
MosaiQ Assays* The MosaiQ system has the potential to offer a flexible menu of multiplex assays for autoimmune diseases and allergies, designed with key markers as per recommended clinical guidelines ...
The MosaiQ AiPlex CD is designed to improve the accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows The MosaiQ AiPlex CD multiplex assay, which received IVDR-CE mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback